ExpreS2ion Biotechnologies: First Immunogenicity Confirmation from Breast Cancer Study
4 september, 12:08
4 september, 12:08
ExpreS2ion today announced the first immunogenicity results from one patient after six weeks of treatment. The data indicate that the vaccine is triggering a significant immune response.
4 september, 12:08
ExpreS2ion today announced the first immunogenicity results from one patient after six weeks of treatment. The data indicate that the vaccine is triggering a significant immune response.
Skattesänkningarna
Guldrushen
PPM-upphandlingen
Skattesänkningarna
Guldrushen
PPM-upphandlingen
1 DAG %
Senast
Broadcom
Idag, 20:15
Apple och Tesla sjunker mot strömmen
SCA
Idag, 17:52
Börsen upp 0,5%, med Swedbank som lok
OMX Stockholm 30
1 DAG %
Senast
2 640,24